Clinical trial
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
NCT00141115 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00141115 |
|---|---|
| Title | Levetiracetam for the Treatment of Alcohol Dependence and Anxiety |
| Official title | Pilot Trial of Levetiracetam in the Treatment of Alcohol Dependence With Comorbid Anxiety |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Generalized Anxiety Disorder, Panic Disorder, Social Phobia, Anxiety Disorders |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 3 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Apr 24, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: